CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Formáid: Artigo
Teanga:Russo
Foilsithe: IRBIS LLC 2016-02-01
Sraith:Фармакоэкономика
Ábhair:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Rochtain Ar Líne:https://www.pharmacoeconomics.ru/jour/article/view/130
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla